Articles

QPP is continuously involved in research, projects and developing information that can help people live well with HIV in Queensland. Read the latest updates here.

Articles

Home » Articles
  • Long Acting HIV Treatment: 5 Myths and Realities

    Introduction: Long-acting antiretrovirals: Are they the future of HIV treatment or will the future pass them by? As research progresses on long-acting antiretroviral therapy (LA-ART) for HIV — also sometimes referred to as extended-release (ER) antiretroviral therapy — experts disagree about …

  • A LOOK INTO THE GREY ZONE: AGEING WITH HIV

    Ageing with HIV, can be both a celebration and a concern. A celebration because effective HIV treatments have given life-years back to all people on effective treatment; but a concern since people are now moving into older age with HIV and …

  • Give the Flu the Flick

    Yes folks, it’s that time of year again to get flu vaccinated and build up our winter defences against the debilitating effects of influenza. The official flu season typically spans from May to October each year. Flu vaccination is available from …

  • Bictegravir – A new Integrase Inhibitor in the pipeline

    Bictegravir matches dolutegravir for first-line treatment in Phase 2 studies Paul Sax at CROI 2017. Photo by Liz Highleyman, hivandhepatitis.com Bictegravir, an investigational new integrase inhibitor, was highly potent, well tolerated and worked as well as dolutegravir (Tivicay – an existing …

  • Doravirine – a new NNRTI (Non-Nuke) option on the horizon

    Kathleen Squires at CROI 2017. Photo by Liz Highleyman, hivandhepatitis.com Doravirine, an investigational next-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) that reduced HIV viral load as well as boosted darunavir (a Protease Inhibitor) in a phase 3 clinical trial of people starting …

icon-angle icon-bars icon-times